Loreal, FR0000120321

UBS raises target for L'Oreal stock from EUR 430.00 to EUR 440.00

Published on 10/12/2026 at 10:34 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

First-half revenue rose 5.8 percent to EUR 23.77 billion. L'Oreal stock costs EUR 382.78 on October 12, 2026, plus 0.43 percent versus EUR 381.15.

Key points in brief

  • UBS raised its L'Oreal price target from EUR 430.00 to EUR 440.00 on October 5, 2026 and kept a Buy rating.
  • First-half 2026 revenue rose 5.8 percent to EUR 23.77 billion, while earnings per share increased to EUR 6.65 from EUR 6.31.
  • L'Oreal stock was at EUR 382.78 at Lang & Schwarz on October 12, 2026, plus 0.43 percent versus the October 9 Xetra close of EUR 381.15.
  • L'Oreal's next sales update is scheduled for October 22, 2026, after the market close.
Bauhaus-Poster mit geometrischen Formen, Lippenstift-Silhouette und Text COSMETICS PARIS CAC 40
Dieses Bauhaus-Poster mit Sektor-Text verweist auf L'Oréal S.A. (FR0000120321) als Kosmetikkonzern in Paris, Illustration mit AI erstellt.

L'Oreal stock was at EUR 382.78 at Lang & Schwarz on October 12, 2026 at 10:31 a.m. CEST, plus 0.43 percent versus the Xetra close of October 9, 2026 at EUR 381.15. According to wallstreetONLINE on October 6, 2026, UBS raised its target from EUR 430.00 to EUR 440.00 and kept a Buy rating in a note dated October 5, 2026.

Target rises to EUR 440.00

The UBS view places the target 14.95 percent above the Lang & Schwarz price of EUR 382.78. Its analyst expected like-for-like sales growth of 6.00 percent in the third quarter, despite demanding comparisons with the prior-year period, and L'Oreal plans to publish its sales update on October 22, 2026, after the market close.

What do the results show?

According to Simply Wall St, first-half 2026 revenue reached EUR 23.77 billion, up 5.80 percent from the first half of 2025. Earnings per share rose to EUR 6.65 from EUR 6.31, while net income reached EUR 3.55 billion, up 5.30 percent year over year.

The earnings profile gives the October sales update a clear test: UBS expects 6.00 percent like-for-like growth, while the reported first-half revenue increase was 5.80 percent. That comparison leaves execution against the third-quarter benchmark as the next measurable signal for the valuation.

Three milestones shape the story

On March 31, 2026, L'Oreal completed its EUR 4.00 billion purchase of Kering Beaute, including the Creed brand and long-term luxury beauty licences, according to EPR. On July 29, 2026, L'Oreal reported first-half revenue of EUR 23.77 billion through its investor-relations calendar.

On October 5, 2026, UBS set the higher EUR 440.00 target, the latest dated event in this sequence. The next scheduled company date is October 22, 2026, when L'Oreal is due to publish sales for the period ended September 30, 2026, after the market close, according to L'Oreal Finance.

Stock remains near EUR 383.00

L'Oreal was trading at EUR 382.78 at Lang & Schwarz on October 12, 2026 at 10:31 a.m. CEST, plus 0.43 percent versus the Xetra close of October 9, 2026 at EUR 381.15. The quote remains below the EUR 440.00 UBS target, with the October 22 sales release providing the next dated operating checkpoint. The further course of trading is shown by the continuously updated real-time quote of L'Oreal stock.

L'Oreal stock facts

  • Company: L'Oreal S.A.
  • ISIN: FR0000120321
  • Ticker: OR
  • Primary exchange: Euronext Paris
  • Price Lang & Schwarz as of October 12, 2026, 10:31 a.m. CEST: EUR 382.78
  • Change versus Xetra close: plus 0.43 percent
  • Xetra close October 9, 2026: EUR 381.15
  • Market capitalization: EUR 203.7 billion (as of October 12, 2026)
  • Sector / Industry: Consumer Staples / Personal Products
  • Index membership: CAC 40
  • Next earnings date: October 22, 2026

Market context: Market report CAC 40.

More news and analyses on L'Oreal stock

Disclaimer...

en | FR0000120321 | LOREAL | boerse | 70299099 | bgmi